Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Aravindhan Veerapandiyan to Humans

This is a "connection" page, showing publications Aravindhan Veerapandiyan has written about Humans.

 
Connection Strength
  
 
 
0.996
  
  1. Grabich S, Ung B, Nadkar A, DeYoung K, Signorovitch J, Veerapandiyan A. Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis. J Comp Eff Res. 2025 Aug; 14(8):e250037.
    View in: PubMed
    Score: 0.040
  2. Hamid OA, Hester DM, Matesanz SE, Wright S, Batley KY, Proud CM, Veerapandiyan A. Equitable Access of Delandistrogene Moxeparvovec for Patients With Duchenne Muscular Dystrophy: A Call for Discussion. Pediatr Neurol. 2024 Oct; 159:33-34.
    View in: PubMed
    Score: 0.038
  3. Veerapandiyan A, Duvuru R. Transforming care for spinal muscular atrophy: A critical look at treatment paradigms. Mol Ther. 2024 Aug 07; 32(8):2435-2436.
    View in: PubMed
    Score: 0.037
  4. Duvuru R, Hobart-Porter L, Veerapandiyan A. Revolutionizing neuromuscular disorders rehabilitation: The virtual reality edge. Muscle Nerve. 2024 Aug; 70(2):163-165.
    View in: PubMed
    Score: 0.037
  5. Schuberth K, Ramani PK, Beemarajan E, Veerapandiyan A. Child Neurology: KMT2B-Related Dystonia in a Young Child With Worsening Gait Abnormality. Neurology. 2023 08 15; 101(7):328-332.
    View in: PubMed
    Score: 0.034
  6. ElSheikh RH, Aravindhan A, Boysen S, Veerapandiyan A. Infantile-Onset Complex Hereditary Spastic Paraplegia Due to a Novel Mutation in SPAST Gene. Pediatr Neurol. 2022 09; 134:71.
    View in: PubMed
    Score: 0.033
  7. Veerapandiyan A, Rao VK. Palliative care in Duchenne muscular dystrophy: Goals of care discussions and beyond. Muscle Nerve. 2022 06; 65(6):627-629.
    View in: PubMed
    Score: 0.032
  8. Boysen S, Elumalai V, ElSheikh RH, Aravindhan A, Veerapandiyan A. Epilepsy in hereditary spastic paraplegia associated with NIPA1 gene. J Clin Neurosci. 2022 06; 100:212-213.
    View in: PubMed
    Score: 0.032
  9. Sharma R, Aravindhan A, Puente C, Veerapandiyan A. Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay due to Novel Mutations in the SACS Gene. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221139670.
    View in: PubMed
    Score: 0.031
  10. Dhasakeerthi T, Aravindhan A, Woodall A, Mills W, Veerapandiyan A. Congenital Myasthenic Syndrome due to a Novel Mutation in CHAT Gene. J Clin Neuromuscul Dis. 2021 Sep 01; 23(1):54-55.
    View in: PubMed
    Score: 0.031
  11. Lewis HS, Srinivasa Sekaran BS, Stefans V, Veerapandiyan A. Clinical Reasoning: A 6-Year-Old Boy With Muscle Twitching. Neurology. 2021 01 12; 96(2):e301-e304.
    View in: PubMed
    Score: 0.029
  12. Harada Y, Rao VK, Arya K, Kuntz NL, DiDonato CJ, Napchan-Pomerantz G, Agarwal A, Stefans V, Katsuno M, Veerapandiyan A. Combination molecular therapies for type 1 spinal muscular atrophy. Muscle Nerve. 2020 10; 62(4):550-554.
    View in: PubMed
    Score: 0.029
  13. Ranabothu S, Onteddu S, Nalleballe K, Dandu V, Veerapaneni K, Veerapandiyan A. Spectrum of COVID-19 in children. Acta Paediatr. 2020 09; 109(9):1899-1900.
    View in: PubMed
    Score: 0.028
  14. Malatesta L, Arya K, Gokden M, Stefans V, Veerapandiyan A. BAG3 Myopathy Presenting With Prominent Neuropathic Phenotype and No Cardiac or Respiratory Involvement: A Case Report and Literature Review. J Clin Neuromuscul Dis. 2020 Jun; 21(4):230-239.
    View in: PubMed
    Score: 0.028
  15. Saylam E, Aravindhan A, Stefans V, Veerapandiyan A. Pseudometabolic Presentation of Dystrophinopathy in a Family Due to a Rare Nonsense Mutation. J Clin Neuromuscul Dis. 2020 Jun; 21(4):245-246.
    View in: PubMed
    Score: 0.028
  16. Veerapandiyan A, Wagner KR, Apkon S, McDonald CM, Mathews KD, Parsons JA, Wong BL, Eichinger K, Shieh PB, Butterfield RJ, Rao VK, Smith EC, Proud CM, Connolly AM, Ciafaloni E. The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic. Muscle Nerve. 2020 07; 62(1):41-45.
    View in: PubMed
    Score: 0.028
  17. Veerapandiyan A, Connolly AM, Finkel RS, Arya K, Mathews KD, Smith EC, Castro D, Butterfield RJ, Parsons JA, Servais L, Kuntz N, Rao VK, Brandsema JF, Mercuri E, Ciafaloni E. Spinal muscular atrophy care in the COVID-19 pandemic era. Muscle Nerve. 2020 07; 62(1):46-49.
    View in: PubMed
    Score: 0.028
  18. Harada Y, Zuchner SL, Herrmann DN, Veerapandiyan A. Clinical Reasoning: A case of bilateral foot drop in a 74-year-old man. Neurology. 2020 03 03; 94(9):405-409.
    View in: PubMed
    Score: 0.028
  19. Guess KE, Harada Y, Hill A, Ferry J, Veerapandiyan A. A Toddler With Bilateral Facial Weakness. Clin Pediatr (Phila). 2020 05; 59(4-5):529-531.
    View in: PubMed
    Score: 0.027
  20. Veerapandiyan A, Eichinger K, Guntrum D, Kwon J, Baker L, Collins E, Ciafaloni E. Nusinersen for older patients with spinal muscular atrophy: A real-world clinical setting experience. Muscle Nerve. 2020 02; 61(2):222-226.
    View in: PubMed
    Score: 0.027
  21. Lewis HS, Willis E, Veerapandiyan A. Charcot-Marie-Tooth Disease Type 4J and Multiple Sclerosis. J Clin Neuromuscul Dis. 2019 Dec; 21(2):117-118.
    View in: PubMed
    Score: 0.027
  22. Veerapandiyan A, Oh D, Kornitzer J. Distal 1q21.1 and proximal 1q21.2 microduplication in a child with attention-deficit hyperactivity disorder. Acta Neurol Belg. 2019 Jun; 119(2):289-290.
    View in: PubMed
    Score: 0.025
  23. Veerapandiyan A, Pal R, D'Ambrosio S, Young I, Eichinger K, Collins E, Westesson PL, Kwon J, Ciafaloni E. Cervical puncture to deliver nusinersen in patients with spinal muscular atrophy. Neurology. 2018 08 14; 91(7):e620-e624.
    View in: PubMed
    Score: 0.025
  24. Veerapandiyan A, Aravindhan A, Takahashi JH, Segal D, Pecor K, Ming X. Use of Head Computed Tomography (CT) in the Pediatric Emergency Department in Evaluation of Children With New-Onset Afebrile Seizure. J Child Neurol. 2018 10; 33(11):708-712.
    View in: PubMed
    Score: 0.025
  25. Aravindhan A, Shah K, Pak J, Veerapandiyan A. Early-onset epileptic encephalopathy with myoclonic seizures related to 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes. Epileptic Disord. 2018 Jun 01; 20(3):214-218.
    View in: PubMed
    Score: 0.025
  26. Veerapandiyan A, Chaudhari A, Deo P, Ming X. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): A pediatric case report with six year follow-up. Mult Scler Relat Disord. 2017 Oct; 17:95-98.
    View in: PubMed
    Score: 0.023
  27. Veerapandiyan A, Singh P, Mikati MA. Possible induction of West syndrome by oxcarbazepine therapy in a patient with complex partial seizures. Epileptic Disord. 2012 Mar; 14(1):99-103.
    View in: PubMed
    Score: 0.016
  28. Veerapandiyan A, Abdul-Rahman OA, Adam MP, Lyons MJ, Manning M, Coleman K, Kobrynski L, Taneja D, Schoch K, Zimmerman HH, Shashi V. Chromosome 22q11.2 deletion syndrome in African-American patients: a diagnostic challenge. Am J Med Genet A. 2011 Sep; 155A(9):2186-95.
    View in: PubMed
    Score: 0.015
  29. Veerapandiyan A, Gallentine WB, Winchester SA, Baker J, Kansagra SM, Mikati MA. Oculogyric crises secondary to lamotrigine overdosage. Epilepsia. 2011 Mar; 52(3):e4-6.
    View in: PubMed
    Score: 0.015
  30. Veerapandiyan A, Blalock D, Ghosh S, Ip E, Barnes C, Shashi V. The role of cephalometry in assessing velopharyngeal dysfunction in velocardiofacial syndrome. Laryngoscope. 2011 Apr; 121(4):732-7.
    View in: PubMed
    Score: 0.015
  31. Veerapandiyan A, Winchester SA, Gallentine WB, Smith EC, Kansagra S, Hyland K, Mikati MA. Electroencephalographic and seizure manifestations of pyridoxal 5'-phosphate-dependent epilepsy. Epilepsy Behav. 2011 Mar; 20(3):494-501.
    View in: PubMed
    Score: 0.015
  32. Veerapandiyan A, Shashi V, Jiang YH, Gallentine WB, Schoch K, Smith EC. Pseudometabolic presentation of dystrophinopathy due to a missense mutation. Muscle Nerve. 2010 Dec; 42(6):975-9.
    View in: PubMed
    Score: 0.015
  33. Veerapandiyan A, Chinn IK, Schoch K, Maloney KA, Shashi V. Reactive lymphoid hyperplasia in association with 22q11.2 deletion syndrome and a BRCA2 mutation. Eur J Med Genet. 2011 Jan-Feb; 54(1):63-6.
    View in: PubMed
    Score: 0.014
  34. Baldi O, Kinnett K, Schrader R, Denger B, Truba N, Sorensen S, Veerapandiyan A, Colvin MK. Gaps in the Assessment and Care of Neurodevelopmental and Psychiatric Conditions Associated With Dystrophinopathy. Muscle Nerve. 2025 Mar; 71(3):377-383.
    View in: PubMed
    Score: 0.010
  35. Kaufman BD, Veerapandiyan A, Soslow JH, Wittlieb-Weber C, Esteso P, Olson AK, Shih R, Bansal N, Lal A, Gambetta K, Hsu D, Cripe L, Villa C, Nandi D. Taking ACTION to detect myocarditis related to recombinant gene transfer therapy for Duchenne Muscular Dystrophy; Consensus recommendations for cardiac surveillance. J Neuromuscul Dis. 2025 Mar; 12(2):173-182.
    View in: PubMed
    Score: 0.010
  36. Truba N, Sorensen S, Bearden R, Haley B, Spray B, Kinnett K, Schrader R, Veerapandiyan A, Colvin MK. The BELS questionnaire: A novel screening tool for neurodevelopmental and psychiatric symptoms in pediatric dystrophinopathy. Muscle Nerve. 2025 Feb; 71(2):153-158.
    View in: PubMed
    Score: 0.010
  37. Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial. Nat Med. 2025 Jan; 31(1):332-341.
    View in: PubMed
    Score: 0.010
  38. Zaidman CM, Goedeker NL, Aqul AA, Butterfield RJ, Connolly AM, Crystal RG, Godwin KE, Hor KN, Mathews KD, Proud CM, Kula Smyth E, Veerapandiyan A, Watkins PB, Mendell JR. Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2024; 11(3):687-699.
    View in: PubMed
    Score: 0.009
  39. Kwon JM, Arya K, Kuntz N, Phan HC, Sieburg C, Swoboda KJ, Veerapandiyan A, Assman B, Bader-Weder S, Dickendesher TL, Hansen J, Lin H, Yan Y, Rao VK. An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. Ann Clin Transl Neurol. 2022 06; 9(6):810-818.
    View in: PubMed
    Score: 0.008
  40. Steele JL, Morrow MM, Sarnat HB, Alkhunaizi E, Brandt T, Chitayat DA, DeFilippo CP, Douglas GV, Dubbs HA, Elloumi HZ, Glassford MR, Hannibal MC, H?ron B, Kim LE, Marco EJ, Mignot C, Monaghan KG, Myers KA, Parikh S, Quinonez SC, Rajabi F, Shankar SP, Shinawi MS, van de Kamp JJP, Veerapandiyan A, Waldman AT, Graf WD. Semaphorin-Plexin Signaling: From Axonal Guidance to a New X-Linked Intellectual Disability Syndrome. Pediatr Neurol. 2022 01; 126:65-73.
    View in: PubMed
    Score: 0.008
  41. Weerasinghe D, Veerapandiyan A, Stanton M, Herrmann DN, Akmyradov C, Logigian E. Recovery of foot drop in chronic inflammatory demyelinating polyneuropathy (CIDP). Muscle Nerve. 2021 07; 64(1):59-63.
    View in: PubMed
    Score: 0.007
  42. Feldman AG, Parsons JA, Dutmer CM, Veerapandiyan A, Hafberg E, Maloney N, Mack CL. Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1. J Pediatr. 2020 10; 225:252-258.e1.
    View in: PubMed
    Score: 0.007
  43. Silverstein S, Veerapandiyan A, Hayes-Rosen C, Ming X, Kornitzer J. A novel intronic homozygous mutation in the AMT gene of a patient with nonketotic hyperglycinemia and hyperammonemia. Metab Brain Dis. 2019 02; 34(1):373-376.
    View in: PubMed
    Score: 0.006
  44. Aravindhan A, Veerapandiyan A, Earley C, Thulasi V, Kresge C, Kornitzer J. Child Neurology: Type 1 sialidosis due to a novel mutation in NEU1 gene. Neurology. 2018 03 27; 90(13):622-624.
    View in: PubMed
    Score: 0.006
  45. Leonard AS, Hyder SN, Kolls BJ, Arehart E, Ng KC, Veerapandiyan A, Mikati MA. Seizure predisposition after perinatal hypoxia: effects of subsequent age and of an epilepsy predisposing gene mutation. Epilepsia. 2013 Oct; 54(10):1789-800.
    View in: PubMed
    Score: 0.004
  46. Steele SU, Cheah SM, Veerapandiyan A, Gallentine W, Smith EC, Mikati MA. Electroencephalographic and seizure manifestations in two patients with folate receptor autoimmune antibody-mediated primary cerebral folate deficiency. Epilepsy Behav. 2012 Aug; 24(4):507-12.
    View in: PubMed
    Score: 0.004
  47. Shashi V, Veerapandiyan A, Keshavan MS, Zapadka M, Schoch K, Kwapil TR, Hooper SR, Stanley JA. Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry. 2012 Oct 15; 72(8):684-91.
    View in: PubMed
    Score: 0.004
  48. Shah R, Veerapandiyan A, Winchester S, Gallentine W, Mikati MA. Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies. Pediatr Neurol. 2011 Dec; 45(6):412-6.
    View in: PubMed
    Score: 0.004
  49. Shashi V, Veerapandiyan A, Schoch K, Kwapil T, Keshavan M, Ip E, Hooper S. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. J Intellect Disabil Res. 2012 Sep; 56(9):865-78.
    View in: PubMed
    Score: 0.004
  50. Holt RL, Provenzale JM, Veerapandiyan A, Moon WJ, De Bellis MD, Leonard S, Gallentine WB, Grant GA, Egger H, Song AW, Mikati MA. Structural connectivity of the frontal lobe in children with drug-resistant partial epilepsy. Epilepsy Behav. 2011 May; 21(1):65-70.
    View in: PubMed
    Score: 0.004
  51. Goldstein JL, Austin SL, Boyette K, Kanaly A, Veerapandiyan A, Rehder C, Kishnani PS, Bali DS. Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III. Genet Med. 2010 Jul; 12(7):424-30.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.